83 related articles for article (PubMed ID: 33801478)
1. The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
Mercadante S; Maltoni M; Russo D; Adile C; Ferrera P; Rossi R; Rosati M; Casuccio A
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801478
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
[TBL] [Abstract][Full Text] [Related]
4. Canadian recommendations for the management of breakthrough cancer pain.
Daeninck P; Gagnon B; Gallagher R; Henderson JD; Shir Y; Zimmermann C; Lapointe B
Curr Oncol; 2016 Apr; 23(2):96-108. PubMed ID: 27122974
[TBL] [Abstract][Full Text] [Related]
5. Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer.
Pointreau Y; Bensadoun RJ; Bera G; Sire C; Ruffier A; Janoray G; Calais G; Bollet M; Pinel B; Braniste V; Amores X
Patient Prefer Adherence; 2020; 14():859-868. PubMed ID: 32546980
[TBL] [Abstract][Full Text] [Related]
6. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment.
Reis-Pina P; Acharya A; Barbosa A; Lawlor PG
Pain Res Manag; 2020; 2020():6190862. PubMed ID: 32566062
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Gabapentin as a Treatment of Breakthrough Cancer Pain Caused by Metastatic Prostate Adenocarcinoma.
Ismy J; Emril DR; Khalilullah SA; Mauny MP
J Pain Res; 2023; 16():3319-3324. PubMed ID: 37808465
[TBL] [Abstract][Full Text] [Related]
8. Pain Intensity and Satisfaction of Pain Relief in Discharged Cancer Patients: A Large Sample Study in China.
Yang H; Zhang S; Ma X; Li X; Yu W; Hao L; Lu Y
Pain Manag Nurs; 2024 Apr; ():. PubMed ID: 38609804
[TBL] [Abstract][Full Text] [Related]
9. Race, pain, and opioids among patients with chronic pain in a safety-net health system.
Haq N; McMahan VM; Torres A; Santos GM; Knight K; Kushel M; Coffin PO
Drug Alcohol Depend; 2021 May; 222():108671. PubMed ID: 33810908
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study.
Mercadante S; Caraceni A; Cuomo A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G
J Clin Med; 2021 May; 10(11):. PubMed ID: 34073907
[TBL] [Abstract][Full Text] [Related]
11. Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study.
Cascella M; Crispo A; Esposito G; Forte CA; Coluccia S; Porciello G; Amore A; Bimonte S; Mercadante S; Caraceni A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G; Cuomo A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439173
[TBL] [Abstract][Full Text] [Related]
12. What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations.
Bossi P; Antonuzzo A; Armento G; Consoli F; Giuliani J; Giusti R; Lucchesi M; Mirabile A; Palermo L; Scagliarini S
Cancer Manag Res; 2021; 13():5203-5210. PubMed ID: 34234563
[TBL] [Abstract][Full Text] [Related]
13. A rapid systematic review of breakthrough pain definitions and descriptions.
Greenfield K; Schoth DE; Hain R; Bailey S; Mott C; Rajapakse D; Harrop E; Renton K; Anderson AK; Carter B; Johnson M; Liossi C
Br J Pain; 2024 Jun; 18(3):215-226. PubMed ID: 38751563
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study.
Tekie Y; Nigatu YA; Mekonnen W; Berhe YW
Front Oncol; 2023; 13():1248921. PubMed ID: 38264754
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of qualitative research exploring patient and health professional perspectives of breakthrough cancer pain.
Crawford GB; Lakhani A; Palmer L; Sebalj M; Rolan P
Support Care Cancer; 2023 Oct; 31(12):619. PubMed ID: 37812248
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Insights in cancer pain: 2022.
Okifuji A
Front Pain Res (Lausanne); 2023; 4():1236538. PubMed ID: 37521942
[No Abstract] [Full Text] [Related]
17. Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques.
Mestdagh F; Steyaert A; Lavand'homme P
Curr Oncol; 2023 Jul; 30(7):6838-6858. PubMed ID: 37504360
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough pain and rapid-onset opioids in patients with cancer pain: a narrative review.
Yeo J
J Yeungnam Med Sci; 2024 Jan; 41(1):22-29. PubMed ID: 37424088
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials.
Smith AE; Muralidharan A; Smith MT
Discov Oncol; 2022 Oct; 13(1):108. PubMed ID: 36258057
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
